CLRB icon

Cellectar Biosciences
CLRB

Overview Fund Trends Analyst Outlook Journalist POV

4 hedge funds and large institutions have $514K invested in Cellectar Biosciences in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$7K

Top Sellers

1
-$50.4K
2
-$33K
3
-$29K
4
Goldman Sachs
Goldman Sachs
New York
-$16K
5
VKH
Virtu KCG Holdings
New York
-$13K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$242K
2
$180K
3
$77K
4
$7K
5
$4K
6
$3K
7
$1K
8
–
9
–
10
–
11
–
12
–
13
–
14
–